Oncology
 |
|
26 march 2020 09:02:33 |
| Vorinostat in patients with resistant BRAFV600E mutated advanced melanoma: a proof of concept study (Future Oncology) |
|
Tweet Future Oncology, Ahead of Print. |
| 197 viewsCategory: Oncology |
 OCEAN: a randomized Phase III study of melphalan flufenamide + dexamethasone to treat relapsed refractory multiple myeloma (Future Oncology)Progression-free survival as a surrogate for overall survival in oncology trials: a methodological systematic review (British Journal of Cancer) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
